Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07184983 · ClinicalTrials.gov registry record · NA

RS-tDCS for Cannabis Use Disorder: The C.A.R.E.S. Initiative

A NA study of Cannabis Use Disorder, sponsored by NYU Langone Health.

Recruiting
Registry status
NA
Development phase
46
Enrollment target
1
Study location

NCT07184983 is a NA study of Cannabis Use Disorder that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 46 participants, below the 108-participant average among 34 other Cannabis Use Disorder trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07184983, a NA study of Cannabis Use Disorder, is actively recruiting participants, sponsored by NYU Langone Health.

RECRUITING
Registry status
NA
Development phase
46 participants
Enrollment target
1
Study location

Study Summary

The purpose of this sham-controlled pilot randomized controlled trial (RCT) is to evaluate the feasibility, safety, and preliminary efficacy of a one-month intervention consisting of 20 home-based active or sham RS-tDCS sessions paired with audio track guided mindfulness meditation practice in otherwise healthy adults seeking to reduce cannabis use in the context of cannabis use disorder (CUD).

Conditions Studied

Interventions

  • BEHAVIORAL Mindfulness meditation
  • DEVICE Sham Transcranial Direct Current Stimulation (tDCS)
  • DEVICE Active Transcranial Direct Current Stimulation (tDCS)

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2025-11-12
Est. Completion 2027-11-01
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT07184983

The ClinicalTrials.gov registry entry for NCT07184983 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 108-participant average among 34 other Cannabis Use Disorder trials with a reported enrollment target (57% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cannabis Use Disorder appearing as the primary indexed condition, and to 3 interventions - of which Mindfulness meditation is the first listed.

NCT07184983 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT07184983 about?

NCT07184983 is a clinical study titled "RS-tDCS for Cannabis Use Disorder: The C.A.R.E.S. Initiative". The purpose of this sham-controlled pilot randomized controlled trial (RCT) is to evaluate the feasibility, safety, and preliminary efficacy of a one-month intervention consisting of 20 home-based active or sham RS-tDCS sessions paired with audio track guided mindfulness meditation practice in other...

What is the current status of trial NCT07184983?

This trial is currently recruiting. It is a NA study. The enrollment target is 46 participants. The study started on 2025-11-12. Estimated completion is 2027-11-01.

What conditions does trial NCT07184983 study?

This clinical trial studies the following conditions: Cannabis Use Disorder.

What interventions are being tested in trial NCT07184983?

The interventions under investigation include: Mindfulness meditation (BEHAVIORAL), Sham Transcranial Direct Current Stimulation (tDCS) (DEVICE), Active Transcranial Direct Current Stimulation (tDCS) (DEVICE).

Who is sponsoring clinical trial NCT07184983?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07184983 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cannabis Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.